MEDICAL PROPERTIES TRUST INC (MPT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 150M 300M 450M Q1 '21: 362.8M Q2 '21: 381.8M Q3 '21: 390.8M Q4 '21: 409.3M Q1 '22: 409.8M Q2 '22: 400.2M Q3 '22: 352.3M Q4 '22: 380.5M Q1 '23: 350.2M Q2 '23: 337.4M Q3 '23: 306.6M Q1 '24: 271.3M Q2 '24: 266.6M Q3 '24: 225.8M Q4 '24: 231.8M Q1 '25: 223.8M Q2 '25: 240.4M Q3 '25: 237.5M Q4 '25: 270.3M Q1 '26: 252.1M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q3 '24 Q2 '25 Q1 '26

Gross Profit Quarterly

0 150M 300M 450M Q1 '21: 320.7M Q2 '21: 371.3M Q3 '21: 378.8M Q4 '21: 372.4M Q1 '22: 315.8M Q2 '22: 344.7M Q3 '22: 350.5M Q4 '22: 364.4M Q1 '23: 168.2M Q2 '23: 308.7M Q3 '23: 277.8M Q1 '24: 230.4M Q2 '24: 262.2M Q3 '24: 218M Q4 '24: 210.7M Q1 '25: 142.4M Q2 '25: 220.6M Q3 '25: 215.2M Q4 '25: 258.9M Q1 '26: 154.7M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q3 '24 Q2 '25 Q1 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

0 50M 100M 150M Q1 '13: 40.8M Q2 '13: 38.6M Q3 '13: 40.5M Q4 '13: 33.7M Q1 '14: 28.7M Q2 '14: 23.8M Q3 '14: 53.2M Q4 '14: 37.3M Q1 '15: 63.7M Q2 '15: 47.9M Q3 '15: 57.1M Q4 '15: 94.6M Q1 '16: 102.5M Q2 '16: 78.5M Q3 '16: 87.9M Q4 '16: 72.7M Q1 '17: 111.5M Q2 '17: 110.3M Q3 '17: 120.7M Q4 '17: 143.1M Q2 '13 Q1 '14 Q4 '14 Q3 '15 Q2 '16 Q1 '17 Q4 '17

Net Income Quarterly

-900M -600M -300M 0 300M 600M 900M Q1 '21: 163.8M Q2 '21: 114.6M Q3 '21: 171.1M Q4 '21: 206.5M Q1 '22: 631.7M Q2 '22: 189.6M Q3 '22: 221.8M Q1 '23: 32.8M Q2 '23: -42M Q3 '23: 116.7M Q4 '23: -663.9M Q1 '24: -875.6M Q2 '24: -320.6M Q3 '24: -801.2M Q4 '24: -412.8M Q1 '25: -118.3M Q2 '25: -98.4M Q3 '25: -77.7M Q4 '25: 17.3M Q1 '26: 32.8M Q2 '21 Q1 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Cost of Revenue Quarterly

-140M -70M 0 70M 140M 210M Q2 '21: 10.5M Q3 '21: 12M Q4 '21: 36.9M Q1 '22: 94M Q2 '22: 55.6M Q3 '22: 1.8M Q4 '22: 16.1M Q1 '23: 182.1M Q2 '23: -28.7M Q3 '23: 28.8M Q4 '23: -72.1M Q1 '24: 40.9M Q2 '24: 4.3M Q3 '24: 7.8M Q4 '24: 21.1M Q1 '25: 81.4M Q2 '25: 19.8M Q3 '25: -22.3M Q4 '25: 11.4M Q1 '26: 97.3M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Operating Cash Flow Quarterly

-80M 0 80M 160M 240M Q2 '21: 176.5M Q3 '21: 212.2M Q4 '21: 234.2M Q1 '22: 179.4M Q2 '22: 164.6M Q3 '22: 213.9M Q4 '22: 181.1M Q1 '23: 135.6M Q2 '23: 76.5M Q3 '23: 158.2M Q4 '23: 135.4M Q1 '24: 74.3M Q2 '24: 35.3M Q3 '24: 59.2M Q4 '24: 76.7M Q1 '25: 384K Q2 '25: 51.7M Q3 '25: 18.6M Q4 '25: 160.1M Q1 '26: -14.3M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Free Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 250M 500M 750M Q4 '19: 494.9M Q1 '20: 522.2M Q2 '20: 528.9M Q3 '20: 532.4M Q1 '21: 577.5M Q2 '21: 589.1M Q3 '21: 597.3M Q1 '22: 598.9M Q2 '22: 599M Q3 '22: 599.3M Q1 '23: 598.3M Q2 '23: 598.3M Q3 '23: 598.6M Q1 '24: 600.3M Q2 '24: 600.1M Q3 '24: 600.2M Q1 '25: 600.6M Q2 '25: 600.8M Q3 '25: 601.1M Q1 '26: 597.7M Q1 '20 Q1 '21 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q2 '20: 0.82 Q3 '20: 0.87 Q4 '20: 0.81 Q1 '21: 0.94 Q2 '21: 0.92 Q3 '21: 0.96 Q4 '21: 1.11 Q1 '22: 1.88 Q2 '22: 2.01 Q3 '22: 2.09 Q4 '23: -0.94 Q1 '24: -2.45 Q2 '24: -2.92 Q3 '24: -4.45 Q4 '24: -4.03 Q1 '25: -2.77 Q2 '25: -2.39 Q3 '25: -1.18 Q4 '25: -0.46 Q1 '26: -0.21 Q3 '20 Q2 '21 Q1 '22 Q4 '23 Q3 '24 Q2 '25 Q1 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.